Reconsidering the Importance of Long‐Term Low‐Level Aluminum Exposure in Renal Failure Patients

Aluminum toxicity is widely considered a problem of the past. However, low‐level aluminum exposure and low but abnormal body burdens of aluminum are common. Aluminon, the routinely used histochemical stain for aluminum in bone, has a low sensitivity. The role of aluminum in renal osteodystrophy needs to be reassessed using more sensitive techniques. Low‐level aluminum exposure also may result in subtle neurological dysfunction, another area that needs further investigation.

[1]  J. Andía,et al.  Adynamic Bone and Chronic Renal Failure: An Overview , 2000 .

[2]  C. Jb,et al.  [Evolution of the aluminum concentration in the final dialysis solution: Multicenter study in Spanish dialysis centers]. , 2000 .

[3]  P. E. Newman,et al.  Alzheimer's disease revisited. , 2000, Medical hypotheses.

[4]  A. Kumar,et al.  Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[5]  Burke,et al.  Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  J. Cannata Andía Adynamic bone and chronic renal failure: an overview. , 2000, The American journal of the medical sciences.

[7]  M. Tsunoda,et al.  Altered dopamine turnover in murine hypothalamus after low-dose continuous oral administration of aluminum. , 1999, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[8]  Raghubir P. Sharma,et al.  Modulation of tumor necrosis factor α expression in mouse brain after exposure to aluminum in drinking water , 1999, Archives of Toxicology.

[9]  J. Cannata-Andía Renal osteodystrophy in Iberoamerica. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  C. Exley A molecular mechanism of aluminium-induced Alzheimer's disease? , 1999, Journal of inorganic biochemistry.

[11]  B. Garrett,et al.  A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  M. Rogers,et al.  A preliminary study of dietary aluminium intake and risk of Alzheimer's disease. , 1999, Age and ageing.

[13]  J. Cannata-Andía,et al.  Hypokinetic azotemic osteodystrophy. , 1998, Kidney international.

[14]  W. Forbes,et al.  Is exposure to aluminum a risk factor for the development of Alzheimer disease?--Yes. , 1998, Archives of neurology.

[15]  V. Hachinski Aluminum exposure and risk of Alzheimer disease. , 1998, Archives of Neurology.

[16]  V. Felipo,et al.  Chronic Exposure to Aluminum Impairs Neuronal Glutamate‐Nitric Oxide‐Cyclic GMP Pathway , 1998, Journal of neurochemistry.

[17]  J. Hdez-Jaras,et al.  Accidental Aluminum Intoxication in Patients Undergoing Acetate-Free Biofiltration , 1998, Nephron.

[18]  D. Munoz Is exposure to aluminum a risk factor for the development of Alzheimer disease?--No. , 1998, Archives of neurology.

[19]  A. Canteros,et al.  Prevention of aluminium exposure through dialysis fluids. Analysis of changes in the last 8 years. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  V. Jorgetti,et al.  Epidemiology of renal osteodystrophy in Iberoamerica. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  P. Massari Disorders of bone and mineral metabolism after renal transplantation. , 1997, Kidney international.

[22]  W. Forbes,et al.  Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? , 1996, Journal of toxicology and environmental health.

[23]  E. Bonucci,et al.  Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  A. Canteros,et al.  Staining of bone aluminium: comparison between aluminon and solochrome azurine and their correlation with bone aluminium content. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  M. D. de Broe,et al.  Adequacy of dialysis: trace elements in dialysis fluids. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  M. Monier‐Faugere,et al.  Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  M. Arduino,et al.  Epidemic aluminum intoxication in hemodialysis patients traced to use of an aluminum pump. , 1995, Kidney international.

[28]  D Hernández,et al.  Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. , 1995, Kidney international.

[29]  Y. Pei,et al.  Risk factors for renal osteodystrophy: A multivariant analysis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  C. Caramelo,et al.  Mechanisms of aluminum-induced microcytosis: lessons from accidental aluminum intoxication. , 1995, Kidney international.

[31]  A. Torres,et al.  Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  B. Lacour,et al.  Gastrointestinal absorption of aluminum in rats using 26Al and accelerator mass spectrometry. , 1993, Clinical nephrology.

[33]  Y. Pei,et al.  The spectrum of bone disease in end-stage renal failure--an evolving disorder. , 1993, Kidney international.

[34]  S. Hummel,et al.  Diagnostic and therapeutic approaches to aluminium overload in dialysed patients--representative study by questionnaire in West German dialysis units in 1989-1990. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  J. Achard,et al.  Use of alkaline calcium salts as phosphate binder in uremic patients. , 1992, Kidney international. Supplement.

[36]  V. Lorenzo,et al.  Effect of parathyroidectomy on aluminum toxicity and azotemic bone disease in the rat , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  J. Cannata,et al.  The parathyroid gland and aluminum overload: an overview. , 1988, Contributions to Nephrology.

[38]  R. Giordano,et al.  Bone aluminum intoxication: an unpreventable sequel of parathyroidectomy? , 1988, Nephron.

[39]  H. Malluche,et al.  Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. , 1986, Kidney international.

[40]  J. Delmez,et al.  Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. , 1986, The New England journal of medicine.

[41]  Rs Rs Evolución de los parámetros de conducción nerviosa en pacientes bajo tratamiento con DPCA. Comparación con pacientes en hemodiálisis. Evolución de parámetros de conducción nerviosa. , 1986 .

[42]  J. Jb Absorción gastrointestinal de aluminio. Análisis de factores implicados , 1986 .

[43]  E. Slatopolsky,et al.  Suppression of parathyroid hormone secretion by aluminum. , 1983, Kidney international.

[44]  J. Harrelson,et al.  Osteomalacia after parathyroidectomy in patients with uremia. , 1982, Annals of internal medicine.

[45]  T. Feest,et al.  FRACTURING DIALYSIS OSTEODYSTROPHY AND DIALYSIS ENCEPHALOPATHY An Epidemiological Survey , 1979, The Lancet.

[46]  W. D. Kaehny,et al.  The dialysis encephalopathy syndrome. Possible aluminum intoxication. , 1976, The New England journal of medicine.